Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Bolen

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Blood Advances|February 17, 2019
PD-L1 and tumor-associated macrophages in de novo DLBCLRonald McCord, Christopher R Bolen, Hartmut Koeppen, et al.
BMC Cancer|March 3, 2022
Prognostic mutational subtyping in de novo diffuse large B-cell lymphomaEugene Kim, Yanwen Jiang, Tao Xu, et al.
Clinical and Vaccine Immunology : CVI|December 11, 2012
Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virusFeng Qian, Christopher R Bolen, Chunxia Jing, et al.
American Journal of Hematology|August 21, 2020
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapyFarheen Mir, Federico Mattiello, Andrew Grigg, et al.
Frontiers in Immunology|June 25, 2019
Quantitative Comparison of Conventional and t-SNE-guided Gating AnalysesShadi Toghi Eshghi, Amelia Au-Yeung, Chikara Takahashi, et al.
JCI Insight|January 24, 2020
Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosusWinston A Haynes, D James Haddon, Vivian K Diep, et al.
Haematologica|April 23, 2026
Circulating tumor DNA at baseline as a prognostic marker in untreated follicular lymphomaCorinna Lutterbeck, Derrick Kaufman, Christopher R Bolen, et al.
Blood|January 29, 2021
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphomaChristopher R Bolen, Federico Mattiello, Michael Herold, et al.
Future Oncology (London, England)|July 27, 2021
Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencingSally E Trabucco, Ethan S Sokol, Sophia L Maund, et al.
Leukemia & Lymphoma|February 10, 2024
NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCLEhsan Tabari, Alexander F Lovejoy, Hai Lin, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Blood Advances|February 17, 2019
PD-L1 and tumor-associated macrophages in de novo DLBCLRonald McCord, Christopher R Bolen, Hartmut Koeppen, et al.
BMC Cancer|March 3, 2022
Prognostic mutational subtyping in de novo diffuse large B-cell lymphomaEugene Kim, Yanwen Jiang, Tao Xu, et al.
Clinical and Vaccine Immunology : CVI|December 11, 2012
Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virusFeng Qian, Christopher R Bolen, Chunxia Jing, et al.
American Journal of Hematology|August 21, 2020
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapyFarheen Mir, Federico Mattiello, Andrew Grigg, et al.
Frontiers in Immunology|June 25, 2019
Quantitative Comparison of Conventional and t-SNE-guided Gating AnalysesShadi Toghi Eshghi, Amelia Au-Yeung, Chikara Takahashi, et al.
JCI Insight|January 24, 2020
Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosusWinston A Haynes, D James Haddon, Vivian K Diep, et al.
Haematologica|April 23, 2026
Circulating tumor DNA at baseline as a prognostic marker in untreated follicular lymphomaCorinna Lutterbeck, Derrick Kaufman, Christopher R Bolen, et al.
Blood|January 29, 2021
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphomaChristopher R Bolen, Federico Mattiello, Michael Herold, et al.
Future Oncology (London, England)|July 27, 2021
Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencingSally E Trabucco, Ethan S Sokol, Sophia L Maund, et al.
Leukemia & Lymphoma|February 10, 2024
NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCLEhsan Tabari, Alexander F Lovejoy, Hai Lin, et al.
Pageof 5